Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.

Sonawane, Kalyani; Castellano, Tara; Washington, Christina; Ting, Jie; Surinach, Andy; Kirshner, Carol; Chhatwal, Jagpreet; Ayer, Turgay; Moore, Kathleen

Sonawane, Kalyani; Castellano, Tara; Washington, Christina; Ting, Jie; Surinach, Andy; Kirshner, Carol; Chhatwal, Jagpreet; Ayer, Turgay; Moore, Kathleen.

Afiliação

Sonawane K; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Castellano T; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
Washington C; Louisiana State University, Department of Gynecologic Oncology, New Orleans, LA, USA.
Ting J; Stephenson Cancer Center at the University of Oklahoma HSC, Oklahoma, City, OK, USA.
Surinach A; Seagen Inc., Bothell, WA, USA.
Kirshner C; Genesis Research, Hoboken, NJ, USA.
Chhatwal J; Value Analytics Labs, Boston, MA, USA.
Ayer T; Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, MA, USA.
Moore K; Georgia Institute of Technology, Department of Industrial and Systems Engineering, Atlanta, GA, USA.

Gynecol Oncol Rep ; 44(Suppl 1): 101101, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36506039

Palavras-chave

Barriers to care; Cervical cancer; Epidemiology; Geographic variation; Second-line treatment; United States

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article